Searched for
PHARMA MSMES
Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
India–New Zealand $20 billion FTA: List of sectors set to gain ground as the deal kicks inIndia and New Zealand have signed a Free Trade Agreement. This pact offers zero-duty access for most Indian exports. Key sectors like texti...
India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...
GST 2.0 Inverted duty structure hurts FMCG, Pharma: Expert flags concernsIndian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...
Several measures announced to cushion exporters from Gulf conflict impact: DGFTIndia is taking steps to help exporters facing challenges due to the Gulf conflict. Key sectors like gems, jewellery, rice, and pharma are ...
ET SME Summit, Dehradun, showcases MSME resilience and growth outlookThe ET Make in India SME Regional Summit in Dehradun on March 20 saw strong industry participation, underscoring the resilience of the regi...
ET Make in India SME Regional Summit to debut in Dehradun on March 20The ET SME summit serves as a platform for small businesses and industry leaders in this region to connect, share ideas, and explore growth...
Small pharma firms may face closure as regulator tightens quality checksMany small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...
Drug companies flag concerns over timeline for carrying out regulator's manufacturing ruleSmall and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...
PMO acts on pharma MSMEs 'crisis call'The PMO has been alerted to potential medicine shortages and price increases due to stringent regulatory actions on pharmaceutical quality....
Pharma companies must file compliance strategyDrugmakers must complete a gap analysis and submit their compliance strategy to extend Schedule M implementation. Small and medium manufact...
Government extends deadline for small drug companies to comply with revised schedule M standardsThe government is expected to extend the deadline for small drug companies to comply with the revised Schedule M standards until December 3...
Health minister seeks legal view on final schedule M draft noticeThe health ministry has sought a legal opinion on extending the deadline for MSMEs to comply with revised Schedule M standards. The final d...
Pharma MSMEs can get govt help to upgrade facilitiesThe health and family welfare ministry has made good manufacturing practices mandatory for pharma companies. A recent notification by the m...
Govt launches three schemes for pharma sector MSMEsThe Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) would facilitate pharmaceutical MSMEs with proven track record to upgra...
Government earmarks Rs 500 crore for scheme to support pharma clusters, MSMEsThe scheme will address the rising demand in terms of support required for existing pharma clusters and MSMEs across the country to improve...
Diwali bonanza for MSMEs: Narendra Modi lists out 12 new policiesThe MSME Outreach Programme will run for 100 days covering 100 Districts throughout the country.